Advertise here
Advertise here
Headlines

Your unique microbiome may be used to improve and personalize your future medical experience

Researchers discuss using the gut microbiome in personalized medicine. Personalized medicine based on an individual’s gut microflora can overcome limitations of current approaches and provide more accurate diagnostics and treatments. Microbiome analysis has shown promise in diagnostics and treatment of diseases, and AI and machine learning can be used to analyze and predict patient responses…

Read More

What to Expect Over the Long Term

Ulcerative colitis (UC) is a long-term illness characterized by unpredictable symptoms that come and go over time. Around half of Americans with UC are in remission, with three types of remission – clinical, endoscopic, and deep. Deep remission does not mean you are cured, and there is still a chance of future flare-ups. It is…

Read More

FDA Expands Label for CVRx Barostim System in HF

The FDA has approved an expanded label for the Barostim neuromodulation system for patients with heart failure, based on longer-term clinical data from the BeAT-HF trial. The system is indicated for patients with class III or II heart failure with certain criteria. The device stimulates carotid baroreceptors and is implanted below the collarbone. The FDA’s…

Read More

Unbound bilirubin, a robust predictor of acute bilirubin encephalopathy in infants

Unbound bilirubin levels can predict the likelihood of acute bilirubin encephalopathy in infants. This suggests that monitoring unbound bilirubin may help identify infants at risk for this serious condition. The article also mentions the use of cookies for analytics, advertising and site improvement, and directs readers to their Cookie Policy and Settings for more information….

Read More

Cytokinetics Heart Drug’s Trial Data Look Competitive With BMS Med Camzyos

An experimental drug from Cytokinetics has shown promising Phase 3 results in improving heart function during exercise for patients with obstructive hypertrophic cardiomyopathy (oHCM), a rare cardiovascular disease. The drug, aficamten, demonstrated a significant increase in peak oxygen uptake compared to a placebo and had a consistent treatment effect across patient subgroups. The drug works…

Read More

RFK Jr.’s Campaign of Conspiracy Theories Is PolitiFact’s 2023 Lie of the Year

Robert F. Kennedy Jr.’s presidential campaign is built on conspiracy theories and anti-vaccine sentiments. He has obtained significant financial backing and support based on these theories, although they have been proven to be false. Kennedy comes from an elite background, with a history of environmental advocacy before becoming focused on vaccines. His efforts to legitimize…

Read More

Cytokinetics’ aficamten helps HCM patients in new study

Cytokinetics announced that their experimental drug, aficamten, significantly improved exercise capacity for patients with obstructive hypertrophic cardiomyopathy (HCM). The study enrolled 300 patients, and after 24 weeks of treatment, those receiving aficamten showed significant improvements in peak oxygen uptake and met the study’s primary goal. The trial also met all 10 of its secondary endpoints….

Read More

Histone acetylation, transcription factor dynamics contribute to gene expression in brain development

Researchers have uncovered a fundamental mechanism that lets neurons know when and how to form complex connections between and among brain cells, contributing to normal brain development. The transcription factor CREB is required for the brain to learn and form memories, and its interaction with CBP stimulates gene expression during brain development. Neuronal activity increases…

Read More

Newest Treatments for Relapsed/Refractory Multiple Myeloma

The newest treatments for relapsed/refractory multiple myeloma are discussed in the content. It is likely to cover the latest advancements in medical treatments for this condition, potentially including new drugs, therapies, or clinical trials. This information could be beneficial for patients, caregivers, or healthcare professionals seeking the most up-to-date options for managing relapsed or refractory…

Read More

EU Seeks to Reduce the Risks for AI

The European Union is implementing stricter regulations for the use of artificial intelligence. The proposed AI Act aims to ensure AI safety while respecting basic rights and democracy. The legislation will apply to large AI companies and includes protective measures, restrictions on biometric identification systems, and bans on social scoring and certain AI technologies. There…

Read More

Medical Bulletin 27/December/2023

The Medical Bulletin from 27 December 2023 states that the website uses cookies for analytics, advertising, and site improvement. By continuing to use the site, users agree to the use of cookies. More information can be found in the Cookie Policy and Cookie Settings. Source link

Read More

AstraZeneca Goes With Gracell to Gain an Edge in Next-Generation Cell Therapies

AstraZeneca has acquired Gracell Biotechnologies for $1 billion, with the potential for additional payments based on regulatory milestones. This acquisition will help AstraZeneca address the challenges of cell therapy manufacturing in cancer treatment and expand into autoimmune diseases. Gracell has developed technologies to shorten manufacturing times and improve the effectiveness of cell therapies, including a…

Read More

Carrum Health, Florida Cancer Institute partner to expand breast cancer care

Carrum Health has collaborated with Florida Cancer Specialists & Research Institute to provide employers in Florida with breast cancer care services. The San Francisco-based company offers a digital platform for self-funded employers to purchase specialty care, focusing on surgical and cancer care. Through their Center of Excellence network, Carrum highlights high-quality surgical centers across the…

Read More

FDA approval of Vevye tops 2023 cornea articles

The top cornea-related articles on Healio in 2023 featured the FDA approval of Vevye for dry eye disease and the efficacy of azithromycin in treating meibomian gland dysfunction. Other articles included the approval of Vyznova cell therapy for bullous keratopathy and tips for navigating secondary dry eye disease. Additionally, a video perspective discussed the importance…

Read More

Food-as-medicine programs need more research

Food-as-medicine programs that address food insecurity and diet-related chronic diseases are gaining attention, but there is little evidence of their effectiveness. A clinical trial was conducted on a program that prescribes healthy food to food-insecure patients with uncontrolled type 2 diabetes. The results showed high engagement in the program, improvement in self-reported diet, and a…

Read More

New model links RNA editing glitch to early-stage type 1 diabetes

A study from Hebrew University’s Hadassah Medical School introduces a new model suggesting that disrupted RNA editing in pancreatic beta cells may trigger an inflammatory response similar to early-stage type 1 diabetes. This challenges the long-held belief of viral involvement and could have implications for T1D treatments and cures. This perspective offers a new insight…

Read More

ICIs in Melanoma: Predicting Immune-related Adverse Events

A study found that routine histopathology reports on melanoma patients can help predict which patients are most likely to develop immune-related adverse events while taking immune checkpoint inhibitors. The study evaluated 511 patients and found that the presence of lymphovascular invasion and NRAS mutation were associated with increased odds of developing all-grade immune-related adverse events….

Read More

Genicular artery embolization improves knee function for 3 months in knee osteoarthritis patients

Genicular artery embolization has been found to improve knee function in patients with knee osteoarthritis for up to 3 months. This minimally invasive procedure targets the genicular arteries that supply blood to the knee joint, reducing pain and improving overall function. By blocking these arteries, the procedure can provide relief for those suffering from knee…

Read More

Biological Aging Process May Be Impacted by These Sleep Traits

Researchers used a case-control design with Mendelian randomization analyses to examine the link between sleep traits and biological aging risk. They found that shorter sleep duration and increased insomnia symptoms were associated with a higher risk of biological aging. These findings suggest that poor sleep habits may contribute to accelerated biological aging processes. The study…

Read More

Andreessen Horowitz on digital health funding in 2024 and AI regulation

investment partner Jay Rughani reflected on the challenges faced in healthcare in 2023, including health worker burnout, staffing shortages, and health disparities. However, he remains optimistic about the potential of digital health and modern technology to improve efficiency and accessibility in healthcare. Rughani discussed the potential of AI in healthcare for 2024, focusing on implementing…

Read More

AI-based tools help monitor GA progression, treatment effects

Dr. Ursula Schmidt-Erfurth discusses the use of AI-based OCT analysis for geographic atrophy at the FLORetina-ICOOR meeting. These tools help identify disease biomarkers and select patients for new complement inhibition treatments. They also allow for monitoring of treatment efficacy, providing crucial information for clinical management. Schmidt-Erfurth emphasizes the importance of this breakthrough in helping patients…

Read More

Hospitals owned by private equity see complications spike 25%

A study published in the Journal of the American Medical Association reveals that hospitals acquired by private equity firms experience a 25% increase in adverse events compared to non-acquired hospitals. The research also suggests that all of the hospital-acquired conditions they studied increased three years after a private equity acquisition compared to control hospitals. This…

Read More

A goldmine for research on brain diseases

Scientific knowledge about the human brain has seen a significant shift in the last few years, leading to a golden age of molecular neuroscience. The Douglas-Bell Canada Brain Bank (DBCBB) has collected over 3,600 specimens over the past 40 years, contributing to numerous discoveries about neurological and psychiatric diseases. Leading researchers around the world are…

Read More

Gallbladder Diet: Foods for Gallbladder Problems

Most people do not pay attention to the health of their gallbladder, but it plays an important role in collecting and storing bile. Gallstones can develop and interfere with the gallbladder’s functioning, causing symptoms like abdominal pain, bloating, and nausea that lead to surgical removal of the gallbladder. Risk factors include obesity, highly processed foods,…

Read More

Starting a Family in Med School Problematic, Say Students

A study involving medical students found that challenges in family planning impact career choice and delay childbearing. The study focused on fourth-year medical students at the University of Toronto, whose average age ranged between 24 and 33, and 23 out of 34 were women. The study noted that surgical specialties offer less support for family…

Read More

Senior Lecturer Post At UPSC In GMCH, Chandigarh

The Government Medical College and Hospital (GMCH) in Chandigarh, India is seeking a Senior Lecturer for their institution. The position is at the University Institute of Nursing, which is affiliated with the University of Punjab. The ideal candidate will have a Master’s degree in Nursing and at least three years of teaching experience. The application…

Read More

Who Spearheads Employee Retention Strategies At AdventHealth? Get This — The Employees

The healthcare industry is facing a workforce crisis, with issues around employee retention and support. AdventHealth has implemented strategies to gather employee feedback and make changes accordingly. CEO Terry Shaw emphasized the importance of understanding the needs and challenges of frontline workers in order to support them effectively. By seeking feedback from all departments, the…

Read More

A New Test Could Save Arthritis Patients Time, Money, and Pain. But Will It Be Used?

Rheumatoid arthritis patients often cycle through multiple drugs before finding relief, due to insurer and pharmacy benefit manager influence. The best-selling drug in history, Humira, is typically the first prescription offered, despite only providing significant relief to half of patients. A new blood test called PrismRA has the potential to revolutionize treatment by identifying patients…

Read More

Bristol Myers to purchase Karuna for $14 billion

Bristol Myers Squibb is set to acquire Karuna Therapeutics for $14 billion, valuing Karuna at $330 per share, a 53% premium to its Thursday price. The deal centers on a drug called KarXT, designed to treat schizophrenia. KarXT is under FDA review and, if approved next year, would introduce the first new class of medicines…

Read More

Improving the Treatment of Sexual Dysfunction in Women

At the French Urology Association’s 2023 conference, Dr. Charlotte Methorst and Dr. Carol Burté discussed the importance of doctors being involved in the detection, assessment, and treatment of female sexual dysfunction. They emphasized the need to spot sexual dysfunction, which can impact quality of life and relationships, and can also be a symptom of other…

Read More
Advertise here
error: Content is protected !!